Post-Caesarean Section Incisional Infiltration With Lidocaine Versus Lidocaine and Epinephrine;
Cairo, 11511, Egypt
NCT Number: NCT02274974
Study to compare between efficacy of post-caesarean section infiltration with lidocaine and epinephrine versus lidocaine only to reduce post-incisional pain.
Looking for future studies?
Notify Me18 year–38 year
Female
Interventional
Phase 4
Cairo, 11511, Egypt
assessment of adding of epinephrine to lidocaine as local infiltrator to post-caesarean section wound in prolongation of its anaesthetic effect.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
•The wound of C.Swill be infiltrated before closure of the skin, with 20 ml of 2% lidocaine.
Other names: local anaesthetic agent.
The wound of C.S will be infiltrated before closure of the skin, with 20 ml of 2% lidocaine and epinephrine in related dose manner 1:200.000.
Other names: local anaesthetic agent.
Time frame: 24 hours
Time frame: 30 min to 90 min
Time frame: 24 hours
Time frame: 24 hours
first time patient start moving after the section
Time frame: 24 hours to 48 hours
Time frame: 7 days
Time frame: 24 hours
<38°c
Ain Shams Maternity Hospital
Other
Post-Caesarean Section Incisional Infiltration With Lidocaine Versus Lidocaine and Epinephrine;Randomized Controlled Trial.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04596163
Cardiac Event, Cardiovascular Diseases
Hong Kong
View Trial DetailsNCT04464304
Incision, Neurologic Manifestations
Portland, Oregon, United States
View Trial DetailsNCT04439552
Acute Pain, Chronic Pain
Boston, Massachusetts, United States
View Trial DetailsNCT05283980
Acute Pain, Behavior
Boston, Massachusetts, United States
View Trial Details